Qingxin Mu
University of Washington
H-index: 32
North America-United States
Top articles of Qingxin Mu
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure | Pharmaceutics | James Griffin Yan Wu Qingxin Mu Xinyan Li Rodney JY Ho | 2023/3/22 |
Iron oxide nanoparticle for targeted chemo-immunotherapy | 2023/3/2 | ||
Biomedical applications and health impacts of emerging nanostructured materials | Frontiers in Bioengineering and Biotechnology | Jianbo Jia Qingxin Mu Hongyu Zhou | 2023/9/1 |
Composition and method to prepare long-acting injectable suspension containing multiple cancer drugs | 2023/4/13 | ||
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response | Jesse Yu Qingxin Mu Millie Fung Xiaolin Xu Linxi Zhu | 2022/8/1 | |
Enzymatic and Cellular Degradation of Carbon-Based Biconcave Nanodisks | Micromachines | Zhiyong Wei Qingxin Mu Hui Wang Guanyou Lin Miqin Zhang | 2022/7/19 |
Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer | Materials Today | Qingxin Mu Guanyou Lin Mike Jeon Hui Wang Fei-Chien Chang | 2021/11/1 |
In vivo Protein Corona Formation: Characterizations, Effects on Engineered Nanoparticles’ Biobehaviors, and Applications | Xue Bai Jiali Wang Qingxin Mu Gaoxing Su | 2021/3/31 | |
A highly selective iron oxide-based imaging nanoparticle for long-term monitoring of drug-induced tumor cell apoptosis | Biomaterials science | Guanyou Lin Qingxin Mu Richard Revia Zachary Stephen Mike Jeon | 2021 |
ICAM-1 targeted drug combination nanoparticles enhanced gemcitabine-paclitaxel exposure and breast cancer suppression in mouse models | Pharmaceutics | Linxi Zhu Qingxin Mu Jesse Yu James I Griffin Xiaolin Xu | 2021/12/31 |
Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis | PLoS One | Qingxin Mu Jesse Yu James I Griffin Yan Wu Linxi Zhu | 2020/3/6 |
Single-layer boron-doped graphene quantum dots for contrast-enhanced in vivo T 1-weighted MRI | Nanoscale horizons | Hui Wang Richard Revia Qingxin Mu Guanyou Lin Charles Yen | 2020 |
Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer Nodules | Pharmaceutical research | Jesse Yu Qingxin Mu Simone Perazzolo James I Griffin Linxi Zhu | 2020/10 |
In vivo serum enabled production of ultrafine nanotherapeutics for cancer treatment | Materials Today | Qingxin Mu Guanyou Lin Zachary R Stephen Seokhwan Chung Hui Wang | 2020/9/1 |
Optimizing a Novel Au-Grafted Lipid Nanoparticle Through Chelation Chemistry for High Photothermal Biologic Activity | Journal of pharmaceutical sciences | Yu Gao Qingxin Mu Lisheng Zhu Ziying Li Rodney JY Ho | 2020/5/1 |
